Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Elife|January 9, 2020
STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cellsJong Wook Kim, Christian Berrios, Miju Kim, et al.
International Journal of Molecular Sciences|October 14, 2022
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical ResectionSara Lonardi, Halla Nimeiri, Chang Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2024
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate CancerChristopher J Sweeney, Russell Petry, Chang Xu, et al.
JTO Clinical and Research Reports|August 1, 2025
Real-World Validity of Tissue-Agnostic Circulating Tumor DNA Response Monitoring in Lung Cancers Treated With Chemotherapy, Immunotherapy, or Targeted AgentsAnne C Chiang, Russell W Madison, Zoe June Assaf, et al.
Developmental Cell|January 6, 2022
YAP1 and PRDM14 converge to promote cell survival and tumorigenesisMiju Kim, Seav Huong Ly, Yingtian Xie, et al.
International Journal of Cancer|June 6, 2009
Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumorsMasahiro Shuda, Reety Arora, Hyun Jin Kwun, et al.
Nature Communications|December 5, 2022
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancerSmruthy Sivakumar, Dexter X Jin, Hanna Tukachinsky, et al.
JAMA Network Open|March 31, 2022
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate CancerRyon P Graf, Virginia Fisher, Janick Weberpals, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2023
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung CancerBruna Pellini, Russell W Madison, Merrida A Childress, et al.
NPJ Precision Oncology|December 9, 2022
Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumorsJessica K Lee, Smruthy Sivakumar, Alexa B Schrock, et al.
Pageof 4